BrainCool AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0005731833
SEK
0.52
-0.01 (-2.08%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About BrainCool AB stock-summary
stock-summary
BrainCool AB
Pharmaceuticals & Biotechnology
BrainCool publ AB is a Sweden-based company active in the healthcare sector. It develops a medical device for therapeutic brain cooling. BrainCool publ AB uses a patented cooling method developed by Dignitana AB, the marker of the DigniCap System for the prevention of chemotherapy-related hair loss. The technology used in the BrainCool System allows cooling of the neck, which helps to speed perfusion and cooling of blood before it reaches the brain. The therapeutic hypothermia device is dedicated to patients suffering from stroke, cardiac arrest, traumatic brain injury or neonatal asphyxia. BrainCool publ AB is a wholly owned subsidiary of Dignitana AB.
Company Coordinates stock-summary
Company Details
Medicon Village, Scheelevagen 2 , LUND None : 223 81
stock-summary
Tel: 46 73 3937076
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
7 Million
(Quarterly Results - Jun 2025)
Net Profit:
-11 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 143 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.06

stock-summary
Return on Equity

-31.43%

stock-summary
Price to Book

1.22